(Q46731184)

24 December 2017

title

Early changes in serum markers of cardiac extra-cellular matrix turnover in patients with uncomplicated hypertension and type II diabetes (English)

1 reference

24 December 2017

0 references

François Alla

1

0 references

Faiez Zannad

6

object named as

Faiez Zannad

1 reference

24 December 2017

3

Anca Radauceanu

1 reference

24 December 2017

Anna Kearney-Schwartz

2

object named as

Anna Kearney-Schwartz

1 reference

24 December 2017

author name string

Sylvie Das Dores

4

1 reference

24 December 2017

Brigitte Dousset

5

1 reference

24 December 2017

publication date

29 September 2005

1 reference

24 December 2017

European Journal of Heart Failure

published in

1 reference

24 December 2017

volume

8

1 reference

24 December 2017

page(s)

147-153

1 reference

24 December 2017

issue

2

1 reference

24 December 2017

Collagen scar formation after acute myocardial infarction: relationships to infarct size, left ventricular function, and coronary artery patency.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.06.008

Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.06.008

Toward the biochemical assessment of myocardial fibrosis in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.06.008

Serum levels of carboxy-terminal propeptide of human type I procollagen are an indicator for the progression of diabetic nephropathy in patients with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.06.008

Biochemical markers of type III and I collagen: association with retinopathy and neuropathy in type 1 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.06.008

The epidemiology of heart failure: the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.06.008

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.06.008

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.06.008

Collagen turnover and its regulation in the normal and hypertrophying heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.06.008

Treatment of congestive heart failure: interfering the aldosterone-cardiac extracellular matrix relationship.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.06.008

Matrix metalloproteinase disruption of the extracellular matrix and cardiac dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.06.008

Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.06.008

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.06.008

Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.06.008

Increased expression of extracellular matrix regulators TIMP1 and MMP1 in deteriorating heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.06.008

Myocardial collagen turnover in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.06.008

Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.06.008

The dynamic interaction between matrix metalloproteinase activity and adverse myocardial remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.06.008

Relations of plasma total TIMP-1 levels to cardiovascular risk factors and echocardiographic measures: the Framingham heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.06.008

High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.06.008

Ventricular dysfunction in early diabetic heart disease: detection, mechanisms and significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.06.008

Cardiovascular effects of insulin-like growth factor-1 and growth hormone in chronic left ventricular failure in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.06.008

Leptin enhances the effect of transforming growth factor beta in increasing type I collagen formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.06.008

Collagen remodelling in myocardia of patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.06.008

Glucose-induced inhibition of in vitro bone mineralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.06.008

10.1016/J.EJHEART.2005.06.008

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

16198628

1 reference

24 December 2017